Natural Killer Cell Mediated Immunity

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Natural Killer Cell Mediated Immunity trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

RecruitingPhase 2

NCT06853223

This Study is Assessing the Safety and Efficacy of Immune Inhibition as a Treatment to Prevent Primary Graft Dysfunction

Lung transplant recipient survival lags other solid organ recipients, with the main early cause of death being primary graft dysfunction (PGD). PGD occurs in up…

United States120 participantsStarted 2025-12-07

Treatment: Maraviroc, Placebo

RecruitingNot Applicable

NCT07195006

Early Life Malnutrition, Environmental Enteric Dysfunction and Microbiome Trajectories

Malnutrition in women of reproductive age remains a public health concern in Sub-Saharan Africa (SSA). Malnutrition during pregnancy affects foetal growth with…

Zimbabwe368 participantsStarted 2025-01-27

Treatment: Malnutrition in pregnancy as exposure, Poor WASH living conditions as exposure

All recent trials (8 shown)

CompletedNot Applicable

NCT04377113

Cellular Immunity and Renal Cell Cancer

Renal cell cancer (RCC) is one of the most important urogenital tumors because of it's high mortality and increasing incidence. RCC, which accounts about 3% of…

Croatia60 participantsStarted 2020-05-24

UnknownNot Applicable

NCT02978274

Natural Killer Cells Reconstitution Kinetics Post Haploidentical Transplantation

Patients undergoing haploidentical allo-HSCT will be prospectively enrolled exploring the NK cells phenotype and functional reconstitution.

China200 participantsStarted 2015-03

Treatment: MMF, MMF

UnknownEarly Phase 1

Natural Killer Cell Mediated Immunity

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

This Study is Assessing the Safety and Efficacy of Immune Inhibition as a Treatment to Prevent Primary Graft Dysfunction

Early Life Malnutrition, Environmental Enteric Dysfunction and Microbiome Trajectories

All recent trials (8 shown)

Cellular Immunity and Renal Cell Cancer

Natural Killer Cells Reconstitution Kinetics Post Haploidentical Transplantation

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

This Study is Assessing the Safety and Efficacy of Immune Inhibition as a Treatment to Prevent Primary Graft Dysfunction

Early Life Malnutrition, Environmental Enteric Dysfunction and Microbiome Trajectories

All recent trials (8 shown)

Cellular Immunity and Renal Cell Cancer

Natural Killer Cells Reconstitution Kinetics Post Haploidentical Transplantation

Effect of NK Cell Immunotherapy on Advanced Lung Adenocarcinoma Adenocarcinoma With EGFR Mutation

Clinical Study of NK Cells in the Treatment of Severe Endometriosis

Human Blood Specimen Collection to Evaluate Immune Cell Function

Immunotherapy of Advanced Cancer Using a Combination Nimotuzumab and NK Cells